About: Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована у квітні 1996 (uk) article scientifique publié en 1996 (fr) im April 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1996 (ast) scientific article published on 01 April 1996 (en)
publication date	wds:Q71317120-EF186EA9-6CAC-447E-AA37-CD74DF3B0CB2
publication date	1996-04-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71317120-3ABFF11F-A35E-44AB-B407-07493C85A489 wds:Q71317120-841A2A1A-40AE-49C4-8AAB-4D5443EAF920 wds:Q71317120-970C5C95-8A1F-4141-85E6-26A56AC0514E wds:Q71317120-A1AB215C-DF4D-4455-A651-E9D2B2BE77AC
author name string	A J Sedman B B Yang S T Forgue N J Hounslow
rdfs:label	Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine (en) Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine (nl)
skos:prefLabel	Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine (en) Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine (nl)
name	Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine (en) Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine (nl)
title	wds:Q71317120-BE45DEB7-6527-471F-B1A8-7C29C775AA1E
title	Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine (en)
page(s)	wds:Q71317120-67E912F5-C7A3-4018-90E1-4461C73E9126
page(s)	356-360
instance of	wds:Q71317120-A1FCAE00-A503-46FC-9002-05B217484305
instance of	scholarly article
PubMed ID	wds:Q71317120-97D7B20C-10B9-4A08-BAA8-2FC2DA60CBD6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8728350
PubMed ID	8728350
published in	wds:Q71317120-F067397C-CB0A-43F8-9692-DFB602F09B4C
published in	The Journal of Clinical Pharmacology
issue	wds:Q71317120-681BD253-C71F-4CA0-AE29-FFC9DB276AC1
volume	wds:Q71317120-2B34EBE1-31D8-48F6-9EDF-2523865E78B6
issue	4
volume	36
DOI	wds:Q71317120-817F7A56-99BE-46CB-BFA9-7EE2333F3E75
DOI	http://dx.doi.org/10.1002/J.1552-4604.1996.TB04212.X
DOI	10.1002/J.1552-4604.1996.TB04212.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71317120
is cites work of	Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors New insights into the pharmacodynamic and pharmacokinetic properties of statins. Clinical Pharmacokinetics of Atorvastatin Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia
is cites work of	wds:Q34478635-ECFDE07C-4046-464F-9E2A-45D6F72CE0D0 wds:Q33959388-CD8ECE31-CE84-49DE-A3E1-2C98E8FEE73C wds:Q35553211-BE2D45FC-259C-4124-84CC-50A7B5B6D38F wds:Q77940062-EFF618B2-ED0A-40EF-A6E0-58F042E79977 wds:Q33832848-617B687E-5794-477B-8430-0933C54A2A64

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software